COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

Conditions: Lambert Eaton Myasthenic Syndrome

First Posted Date: 2013-04-05

Last Posted Date: 2021-10-06

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01825395

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study

Phase 4

Completed

Conditions: Type 1 Diabetes

Interventions: Device: iBGStar meter

First Posted Date: 2013-04-05

Last Posted Date: 2014-05-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100

Registration Number: NCT01825382

Locations: 🇺🇸
Barbara Davis Center, Aurora, Colorado, United States

Heart Failure Management Program Versus Usual Care

Not Applicable

Completed

Conditions: Congestive Heart Failure
Cardiac Failure

Interventions: Other: Heart Failure Usual Care
Other: Heart Failure Disease Management Program

First Posted Date: 2013-04-04

Last Posted Date: 2019-08-07

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 713

Registration Number: NCT01822912

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Optimizing DBS Electrode Placement and Programming

Withdrawn

Conditions: Parkinson's Disease
Essential Tremor

First Posted Date: 2013-03-28

Last Posted Date: 2014-02-20

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01820390

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Department of Neurosurgery, University of Colorado, Aurora, Colorado, United States

Mediators of Abnormal Reproductive Function in Obesity (MARO)

Early Phase 1

Completed

Conditions: Infertility, Female
Obesity

Interventions: Dietary Supplement: Vascepa - Fish Oil
Other: Microdialysis
Drug: Pioglitazone
Drug: Aspirin

First Posted Date: 2013-03-25

Last Posted Date: 2015-03-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 10

Registration Number: NCT01817400

Locations: 🇺🇸
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

Phase 3

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: Acipimox

First Posted Date: 2013-03-22

Last Posted Date: 2022-01-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 28

Registration Number: NCT01816165

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Strength and Function Following Total Hip Arthroplasty

Not Applicable

Completed

Conditions: Total Hip Arthroplasty

Interventions: Behavioral: Multi-Component Rehabilitation (CMC)
Behavioral: Control (CON)

First Posted Date: 2013-03-22

Last Posted Date: 2016-07-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 68

Registration Number: NCT01817010

Locations: 🇺🇸
University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States

Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes

Phase 4

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Metformin
Drug: Placebo

First Posted Date: 2013-03-19

Last Posted Date: 2022-01-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 23

Registration Number: NCT01813929

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes

Phase 3

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Metformin
Drug: Placebo

First Posted Date: 2013-03-11

Last Posted Date: 2021-09-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 52

Registration Number: NCT01808690

Locations: 🇺🇸
Children's Hospital Colorado and University of Colorado Denver Health Sciences Center, Aurora, Colorado, United States

Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart

Phase 4

Completed

Conditions: Idiopathic Dilated Cardiomyopathy

Interventions: Drug: Metoprolol succinate
Drug: Metoprolol succinate + doxazosin
Drug: Carvedilol

First Posted Date: 2013-02-26

Last Posted Date: 2023-11-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 56

Registration Number: NCT01798992

Locations: 🇺🇸
University of Colorado Hospital, Denver, Colorado, United States
🇺🇸
University of Utah Medical Center, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy